Skip to main content
RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.825
+0.018 (2.18%)
At close: Dec 20, 2024, 4:00 PM
0.850
+0.024 (2.93%)
After-hours: Dec 20, 2024, 5:08 PM EST

RAPT Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
131
Market Cap
28.85M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 20221.53M-2.29M-59.95%
Dec 31, 20213.81M-1.23M-24.38%
Dec 31, 20205.04M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IRIDEX 48.43M
Curis 10.26M
IGC Pharma 1.18M
OneMedNet 957.65K
CytoMed Therapeutics 330.25K
Revenue Rankings

RAPT News

More News